ProAssurance Merger with Doctors Co. Clears Key FTC Hurdle with Early Termination
Summary
The Federal Trade Commission has granted early termination of the waiting period for ProAssurance's merger with The Doctors Company. This critical antitrust clearance significantly de-risks the transaction and accelerates its path to completion. The news follows an 8-K filed just minutes earlier, which broadly announced several new regulatory approvals for the pending merger. This specific FCT approval removes a major regulatory hurdle, bringing the deal closer to closing.
At the time of this announcement, PRA was trading at $23.98 on NYSE in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $22.72 to $24.85. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.